Biotestx ApS: Financial statements 2022
CVR: 37965014
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Biotestx ApS (CVR 37965014) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -4,600 and a net result of DKK -83,106 compared with DKK -21,564 the year before. Equity in the 2022 report amounted to DKK -26,405. The company had 1 employee in the financial year.
- Gross Profit
- DKK -4,600
- Profit/Loss
- DKK -83,106
- Equity
- DKK -26,405
- Total Assets
- DKK 3,809
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -5 t. | -83 t. | -26 t. | 1 |
| 2021 | - | -3 t. | -22 t. | 57 t. | 0 |
| 2020 | - | - | -3 t. | 78 t. | 0 |
| 2019 | - | - | 33 t. | 81 t. | 0 |
| 2018 | - | - | 24 t. | 48 t. | 0 |
Official annual report
Keep an eye on Biotestx ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Biotestx ApS has published its annual report for 2021. Gross profit came to DKK -3,375, and the net result was DKK -21,564.
About Biotestx ApS
Biotestx ApS was a Danish company of the type Anpartsselskab based in Risskov, founded in 2016. The company has been dissolved on 5 December 2023. The company was registered under the industry Anden finansiel formidling undtagen forsikring og pensionsforsikring, i.a.n.. According to the 2022 annual report, the company had an average of 1 employee. In 2022, the company reported a gross profit of DKK -4,600 and a net result of DKK -83,106 compared with DKK -21,564 the year before. Equity in the 2022 report amounted to DKK -26,405.